Drug Profile
IBPB 001PH
Alternative Names: IBPB001PH; IBPB001PH (biosimilar) - Inbiopro SolutionsLatest Information Update: 19 Aug 2013
Price :
$50
*
At a glance
- Originator Inbiopro Solutions
- Class Antirheumatics; Biological peptides; Osteoporosis therapies; Proteins
- Mechanism of Action Osteoprotegerin inhibitors; RANK ligand modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Arthritis; Postmenopausal osteoporosis
Most Recent Events
- 19 Aug 2013 No development reported - Clinical-Phase-Unknown for Arthritis in India (unspecified route)
- 19 Aug 2013 No development reported - Clinical-Phase-Unknown for Postmenopausal osteoporosis in India (unspecified route)
- 30 Jun 2010 Clinical trials in Arthritis in India (unspecified route)